Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Neurogene Inc.

    NASDAQ: NGNE · Real-Time Price · USD
    21.90
    -1.02 (-4.45%)
    At close: Jun 06, 2025, 3:59 PM
    22.16
    1.19%
    After-hours: Jun 06, 2025, 05:39 PM EDT

    Neurogene Statistics

    Share Statistics

    Neurogene has 14.26M shares outstanding. The number of shares has increased by 15.02% in one year.

    Shares Outstanding

    n/a
    		 14.26M

    Shares Change (YoY)

    n/a
    		 15.02%

    Shares Change (QoQ)

    n/a
    		 -28.84%

    Owned by Institutions (%)

    n/a
    		 93.57%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,624

    FTD / Avg. Volume

    n/a
    		 0.58%

    Short Selling Information

    The latest short interest is 2.7M, so 18.9% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.7M

    Short % of Shares Out

    n/a
    		 18.9%

    Short % of Float

    n/a
    		 23.99%

    Short Ratio (days to cover)

    n/a
    		 10.74

    Valuation Ratios

    The PE ratio is -5.34 and the forward PE ratio is -4.31. Neurogene's PEG ratio is -0.09.

    PE Ratio

    n/a
    		 -5.34

    Forward PE

    n/a
    		 -4.31

    PS Ratio

    n/a
    		 434.14

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 1.29

    P/FCF Ratio

    n/a
    		 -5.62

    PEG Ratio

    n/a
    		 -0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Neurogene.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 20.84, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 20.84

    Quick Ratio

    n/a
    		 20.84

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 -6883.75

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $8,644.86

    Profits Per Employee

    n/a
    		 $-702,280.37

    Employee Count

    n/a
    		 107

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -38.21% in the last 52 weeks. The beta is 1.58, so Neurogene's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.58

    52-Week Price Change

    n/a
    		 -38.21%

    50-Day Moving Average

    n/a
    		 14.68

    200-Day Moving Average

    n/a
    		 26.2

    Relative Strength Index (RSI)

    n/a
    		 66.73

    Average Volume (20 Days)

    n/a
    		 278,495

    Income Statement

    In the last 12 months, Neurogene had revenue of 925K and earned -75.14M in profits. Earnings per share was -4.43.

    Revenue

    n/a
    		 925K

    Gross Profit

    n/a
    		 -2.32M

    Operating Income

    n/a
    		 -82.61M

    Net Income

    n/a
    		 -75.14M

    EBITDA

    n/a
    		 -71.89M

    EBIT

    n/a
    		 -75.13M

    Earnings Per Share (EPS)

    n/a
    		 -4.43
    Full Income Statement

    Balance Sheet

    The company has 136.59M in cash and 12.43M in debt, giving a net cash position of 124.16M.

    Cash & Cash Equivalents

    n/a
    		 136.59M

    Total Debt

    n/a
    		 12.43M

    Net Cash

    n/a
    		 124.16M

    Retained Earnings

    n/a
    		 -262.3M

    Total Assets

    n/a
    		 315.3M

    Working Capital

    n/a
    		 282.3M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -70.6M and capital expenditures -808K, giving a free cash flow of -71.41M.

    Operating Cash Flow

    n/a
    		 -70.6M

    Capital Expenditures

    n/a
    		 -808K

    Free Cash Flow

    n/a
    		 -71.41M

    FCF Per Share

    n/a
    		 -4.07
    Full Cash Flow Statement

    Margins

    Gross margin is -251.03%, with operating and profit margins of -8930.27% and -8123.68%.

    Gross Margin

    n/a
    		 -251.03%

    Operating Margin

    n/a
    		 -8930.27%

    Pretax Margin

    n/a
    		 -8123.68%

    Profit Margin

    n/a
    		 -8123.68%

    EBITDA Margin

    n/a
    		 -7771.35%

    EBIT Margin

    n/a
    		 -8930.27%

    FCF Margin

    n/a
    		 -7720.11%

    Dividends & Yields

    NGNE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NGNE is $45, which is 96% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $45

    Price Target Difference

    n/a
    		 96%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 19, 2023. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Dec 19, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 5.69

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist